Notably, several high‐confidence epilepsy genes were among the predicted targets, including STXBP1, associated with epileptic encephalopathies; SYNGAP1, a known gene for developmental delay and seizures; WDR45, implicated in neurodegeneration with brain iron accumulation; EEF1A2 and ACHE, linked to epilepsy, synaptic transmission, and muscular disorders. The gene discussed is ACHE; the disease is muscle tissue disorder.